New AI tool accurately predicts how patients would fare after surgeries

An artificial intelligence (AI) tool developed by investigators at the Smidt Heart Institute at Cedars-Sinai and colleagues at two other institutions accurately predicted how patients would fare after surgeries and procedures.

Chinese NMPA approves AstraZeneca’s Calquence for leukaemia

AstraZeneca is currently analysing Calquence to treat various multiple B-cell blood cancers. Credit: Jonathan Weiss/Shutterstock.com. The Chinese National Medical Products Administration (NMPA) has granted approval for AstraZeneca’s

September 5, 2023

DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESS – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Patent Defence Therapeutics Inc.: DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESS 28.06.2023 / 17:21 CET/CEST The issuer

June 29, 2023

Catalent tries to reassure customers about its deal with Novo Holdings

Catalent, a leading contract drug manufacturer, issued an open letter on Monday to reassure customers that a proposed $16.5 billion deal — in which it would

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.